The mTPH2 C1473G single nucleotide polymorphism is not responsible for behavioural differences between mouse strains

Neuroscience Letters

Volumn 431, Issue 1, 2008, Pages 21-25

  Tenner, Katja ^a   Qadri, Fatimunnisa ^a   Bert, Bettina ^b   Voigt, Jörg Peter ^b   Bader, Michael ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Behaviour; C1473G polymorphism; Serotonin; TPH

Indexed keywords

ISOPROTEIN; SEROTONIN; TRYPTOPHAN HYDROXYLASE 2;

ALLELE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN REGION; BRAIN STEM; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC VARIABILITY; GENOTYPE; IN VITRO STUDY; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTONIN BRAIN LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; BRAIN CHEMISTRY; CERCOPITHECUS AETHIOPS; COS CELLS; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, TRANSGENIC; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN ISOFORMS; SEROTONIN; TRYPTOPHAN HYDROXYLASE; VARIATION (GENETICS);

EID: 38049004434     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.11.012     Document Type: Article

References (16)

1. Delgado P.L., and Moreno F.A. Hallucinogens, serotonin and obsessive-compulsive disorder. J. Psychoactive Drugs 30 (1998) 359-366
2. Hornung J.P. The human raphe nuclei and the serotonergic system. J. Chem. Neuroanat. 26 (2003) 331-343
3. Walther D.J., Peter J.U., Bashammakh S., Hortnagl H., Voits M., Fink H., and Bader M. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299 (2003) 76
4. Walther D.J., and Bader M. A unique central tryptophan hydroxylase isoform. Biochem. Pharmacol. 66 (2003) 1673-1680
5. Mockus S.M., Kumer S.C., and Vrana K.E. Carboxyl terminal deletion analysis of tryptophan hydroxylase. Biochim. Biophys. Acta 1342 (1997) 132-140
6. Tenner K., Walther D.J., and Bader M. Influence of human tryptophan hydroxylase 2 N- and C-terminus on enzymatic activity and oligomerization. J. Neurochem. 102 (2007) 1887-1894
7. Yang X.J., and Kaufman S. High-level expression and deletion mutagenesis of human tryptophan hydroxylase. Proc. Natl. Acad. Sci. USA 91 (1994) 6659-6663
8. Zhang X., Beaulieu J.M., Sotnikova T.D., Gainetdinov R.R., and Caron M.G. Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 305 (2004) 217
9. Lucki I., Dalvi A., and Mayorga A.J. Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology (Berl.) 155 (2001) 315-322
10. Yamaguchi T., Sawada M., Kato T., and Nagatsu T. Demonstration of tryptophan 5-monooxygenase activity in human brain by high sensitive high-performance liquid chromatography with fluorometric detection. Biochem. Int. 2 (1981) 295-303
11. Porsolt R.D., Anton G., Blavet N., and Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 47 (1978) 379-391
12. Sakowski S.A., Geddes T.J., and Kuhn D.M. Mouse tryptophan hydroxylase isoform 2 and the role of proline 447 in enzyme function. J. Neurochem. 96 (2006) 758-765
13. Cervo L., Canetta A., Calcagno E., Burbassi S., Sacchetti G., Caccia S., Fracasso C., Albani D., Forloni G., and Invernizzi R.W. Genotype-dependent activity of tryptophan hydroxylase-2 determines the response to citalopram in a mouse model of depression. J. Neurosci. 25 (2005) 8165-8172
14. Perrault G., Morel E., Zivkovic B., and Sanger D.J. Activity of litoxetine and other serotonin uptake inhibitors in the tail suspension test in mice. Pharmacol. Biochem. Behav. 42 (1992) 45-47
15. Steru L., Chermat R., Thierry B., and Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl.) 85 (1985) 367-370
16. Crowley J.J., Blendy J.A., and Lucki I. Strain-dependent antidepressant-like effects of citalopram in the mouse tail suspension test. Psychopharmacology (Berl.) 183 (2005) 257-264